Jefferies Raises Price Target to $22: CORZ Stock Update
ByAinvest
Tuesday, Aug 19, 2025 3:54 pm ET1min read
CORZ--
At CoreWeave’s current price of $99.97, the all-stock deal values Core Scientific shares at roughly $12.35, well below Jefferies’ estimated fair value of $16 to $23. The agreed exchange ratio of 0.1235 means the implied Core Scientific value fluctuates with CoreWeave’s share price swings. If CoreWeave’s stock doesn’t recover ahead of the vote, Jefferies sees room for renegotiation, potentially raising the exchange ratio to 0.16 to 0.20 to bring the implied valuation of CORZ shares back within the $16 to $23 range.
Jefferies analyst Jonathan Petersen maintains a "Buy" rating for Core Scientific and raised the price target from $16.00 to $22.00, a 37.50% increase. The average target price for CORZ is $18.84 with a high estimate of $24.10 and a low estimate of $15.00, implying an upside of 33.33% from the current price of $14.13. The average brokerage recommendation is currently 2.3, indicating an "Outperform" status.
The merger’s success is tied to CoreWeave’s stock performance, with some investors expecting the deal to fail due to the current undervaluation. If CoreWeave's stock doesn’t recover, Jefferies suggests a higher exchange ratio or a collar provision to stabilize the deal against further volatility.
References:
[1] https://au.finance.yahoo.com/news/core-scientific-faces-valuation-disconnect-144739979.html
[2] https://www.coindesk.com/markets/2025/08/18/core-scientific-faces-valuation-disconnect-pt-hiked-to-usd22-jefferies
CRWV--
Jefferies analyst Jonathan Petersen has maintained a "Buy" rating for Core Scientific (CORZ) and raised the price target from $16.00 to $22.00, a 37.50% increase. The average target price for CORZ is $18.84 with a high estimate of $24.10 and a low estimate of $15.00, implying an upside of 33.33% from the current price of $14.13. The average brokerage recommendation is currently 2.3, indicating "Outperform" status.
Core Scientific (CORZ) reported weaker-than-expected revenue but topped adjusted EBITDA estimates in its second-quarter 2025 results. The main focus, however, remains on its proposed merger with AI cloud provider CoreWeave (CRWV), set for a shareholder vote in the fourth quarter. Investment bank Jefferies has highlighted significant valuation discrepancies in the deal.At CoreWeave’s current price of $99.97, the all-stock deal values Core Scientific shares at roughly $12.35, well below Jefferies’ estimated fair value of $16 to $23. The agreed exchange ratio of 0.1235 means the implied Core Scientific value fluctuates with CoreWeave’s share price swings. If CoreWeave’s stock doesn’t recover ahead of the vote, Jefferies sees room for renegotiation, potentially raising the exchange ratio to 0.16 to 0.20 to bring the implied valuation of CORZ shares back within the $16 to $23 range.
Jefferies analyst Jonathan Petersen maintains a "Buy" rating for Core Scientific and raised the price target from $16.00 to $22.00, a 37.50% increase. The average target price for CORZ is $18.84 with a high estimate of $24.10 and a low estimate of $15.00, implying an upside of 33.33% from the current price of $14.13. The average brokerage recommendation is currently 2.3, indicating an "Outperform" status.
The merger’s success is tied to CoreWeave’s stock performance, with some investors expecting the deal to fail due to the current undervaluation. If CoreWeave's stock doesn’t recover, Jefferies suggests a higher exchange ratio or a collar provision to stabilize the deal against further volatility.
References:
[1] https://au.finance.yahoo.com/news/core-scientific-faces-valuation-disconnect-144739979.html
[2] https://www.coindesk.com/markets/2025/08/18/core-scientific-faces-valuation-disconnect-pt-hiked-to-usd22-jefferies
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
Comments
No comments yet